Adapting a Phage to Combat Phage Resistance
Laanto, E., Mäkelä, K., Hoikkala, V., Ravantti, J. J., & Sundberg, L.-R. (2020). Adapting a Phage to Combat Phage Resistance. Antibiotics, 9(6), Article 291. https://doi.org/10.3390/antibiotics9060291
Julkaistu sarjassa
AntibioticsPäivämäärä
2020Oppiaine
Solu- ja molekyylibiologiaBiologisten vuorovaikutusten huippututkimusyksikköNanoscience CenterCell and Molecular BiologyCentre of Excellence in Biological Interactions ResearchNanoscience CenterTekijänoikeudet
© 2020 by the authors. Licensee MDPI, Basel, Switzerland
2020:43 | 2021:47 | 2022:43 | 2023:37 | 2024:55 | 2025:3
Phage therapy is becoming a widely recognized alternative for fighting pathogenic bacteria due to increasing antibiotic resistance problems. However, one of the common concerns related to the use of phages is the evolution of bacterial resistance against the phages, putatively disabling the treatment. Experimental adaptation of the phage (phage training) to infect a resistant host has been used to combat this problem. Yet, there is very little information on the trade-offs of phage infectivity and host range. Here we co-cultured a myophage FCV-1 with its host, the fish pathogen Flavobacterium columnare, in lake water and monitored the interaction for a one-month period. Phage resistance was detected within one day of co-culture in the majority of the bacterial isolates (16 out of the 18 co-evolved clones). The primary phage resistance mechanism suggests defense via surface modifications, as the phage numbers rose in the first two days of the experiment and remained stable thereafter. However, one bacterial isolate had acquired a spacer in its CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat)-Cas locus, indicating that also CRISPR-Cas defense was employed in the phage-host interactions. After a week of co-culture, a phage isolate was obtained that was able to infect 18 out of the 32 otherwise resistant clones isolated during the experiment. Phage genome sequencing revealed several mutations in two open reading frames (ORFs) likely to be involved in the regained infectivity of the evolved phage. Their location in the genome suggests that they encode tail genes. Characterization of this evolved phage, however, showed a direct cost for the ability to infect several otherwise resistant clones—adsorption was significantly lower than in the ancestral phage. This work describes a method for adapting the phage to overcome phage resistance in a fish pathogenic system.
...
Julkaisija
MDPIISSN Hae Julkaisufoorumista
2079-6382Asiasanat
Julkaisu tutkimustietojärjestelmässä
https://converis.jyu.fi/converis/portal/detail/Publication/35839057
Metadata
Näytä kaikki kuvailutiedotKokoelmat
Rahoittaja(t)
Suomen AkatemiaRahoitusohjelmat(t)
Akatemiahanke, SALisätietoja rahoituksesta
his research was funded by the Academy of Finland grants #321985 (EL) and #314939 (LRS) and Jane and Aatos Erkko Foundation. This work resulted from the BONUS Flavophage project supported by BONUS (Art 185), funded jointly by the European Union (EU) and the Academy of Finland.Lisenssi
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Exploring phage-bacterium interactions : new ways to combat a fish pathogen
Laanto, Elina (University of Jyväskylä, 2014) -
Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria
Almeida, Gabriel M. F.; Laanto, Elina; Ashrafi, Roghaleh; Sundberg, Lotta-Riina (American Society for Microbiology, 2019)Metazoans were proposed to host bacteriophages on their mucosal surfaces in a symbiotic relationship, where phages provide an external immunity against bacterial infections and the metazoans provide phages a medium for ... -
Overcoming Bacteriophage Resistance in Phage Therapy
Laanto, Elina (Humana Press, 2023)Antibiotic resistance among pathogenic bacteria is one of the most severe global challenges. It is predicted that over ten million lives will be lost annually by 2050. Phage therapy is a promising alternative to antibiotics. ... -
Engineered bacteriophages : A panacea against pathogenic and drug resistant bacteria
Kakkar, Anuja; Kandwal, Garima; Nayak, Tanmayee; Jaiswal, Lav Kumar; Srivastava, Amit; Gupta, Ankush (Elsevier, 2024)Antimicrobial resistance (AMR) is a major global concern; antibiotics and other regular treatment methods have failed to overcome the increasing number of infectious diseases. Bacteriophages (phages) are viruses that ... -
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strain
Rohde, Christine; Resch, Grégory; Pirnay, Jean-Paul; Blasdel, Bob G.; Debarbieux, Laurent; Gelman, Daniel; Górski, Andrzej; Hazan, Ronen; Huys, Isabelle; Kakabadze, Elene; Łobocka, Małgorzata; Maestri, Alice; De Freitas Almeida, Gabriel; Makalatia, Khatuna; Malik, Danish J.; Mašlaňová, Ivana; Merabishvili, Maia; Pantucek, Roman; Rose, Thomas; Štveráková, Dana; Raemdonck, Hilde Van; Verbeken, Gilbert; Chanishvili, Nina (MDPI, 2018)Phage therapy is increasingly put forward as a “new” potential tool in the fight against antibiotic resistant infections. During the “Centennial Celebration of Bacteriophage Research” conference in Tbilisi, Georgia on 26–29 ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.